Dipna Pharmachem Limited (BOM:543594)

Dipna Pharmachem Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 21, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	368	344	227	150	-	-
Market Cap Growth	105.03%	51.80%	50.78%	-	-	-
Enterprise Value	499	514	406	179	-	-
Last Close Price	13.99	14.30	9.42	10.31	-	-
PE Ratio	16.18	35.30	20.87	16.47	-	-
PS Ratio	0.34	0.28	0.14	0.15	-	-
PB Ratio	0.62	0.89	0.60	0.62	-	-
P/TBV Ratio	0.62	0.89	0.60	0.62	-	-
EV/Sales Ratio	0.47	0.41	0.25	0.18	-	-
EV/EBITDA Ratio	12.60	13.76	11.78	7.60	-	-
EV/EBIT Ratio	12.63	13.80	11.84	7.64	-	-
Debt / Equity Ratio	0.23	0.45	0.52	0.65	5.86	21.74
Debt / EBITDA Ratio	3.48	4.61	5.65	6.76	4.68	30.50
Debt / FCF Ratio	-	-	-	-	3.64	-
Asset Turnover	0.69	0.94	1.56	1.76	2.38	1.43
Inventory Turnover	2.93	3.51	5.61	7.57	10.17	4.64
Quick Ratio	0.53	0.56	0.55	0.82	0.95	0.74
Current Ratio	1.64	1.56	1.60	1.84	1.26	1.21
Return on Equity (ROE)	4.23%	2.56%	3.51%	6.99%	101.02%	4.32%
Return on Assets (ROA)	1.59%	1.76%	2.04%	2.57%	4.44%	1.16%
Return on Invested Capital (ROIC)	3.91%	5.29%	6.86%	6.71%	13.15%	1.55%
Return on Capital Employed (ROCE)	5.70%	7.90%	6.80%	6.60%	28.80%	9.40%
Earnings Yield	5.57%	2.83%	4.79%	6.07%	-	-
FCF Yield	-38.31%	-26.80%	-23.98%	-139.70%	-	-
Buyback Yield / Dilution	-40.32%	-97.02%	-0.50%	-7042.07%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.